<DOC>
	<DOCNO>NCT01075230</DOCNO>
	<brief_summary>The purpose study determine difference hemoglobin level patient undergoing total knee arthroplasty without platelet-rich plasma .</brief_summary>
	<brief_title>Standard Total Knee Arthroplasty Using Platelet Rich Plasma ( PRP )</brief_title>
	<detailed_description />
	<mesh_term>Osteoarthritis</mesh_term>
	<criteria>Patient male female undergoing primary unilateral surgery first surgery stag bilateral total knee replacement second stage least 6 week later Patient agree blind treatment group assignment Patient willing able return followup least six ( 6 ) month postoperative period although long followup may desire Patient agree participate signing IRB approve Informed Consent Form Patient stag bilateral total knee replacement second stage perform less 6 week first stage surgery PRP Patient previous surgery operative knee necessitate removal exist hardware ( e.g . previous osteotomy ) Patient know adverse reaction sensitivity bovine ( cow ) thrombin ( used part platelet rich plasma system ) bovinederived product Patient hemoglobin &lt; 12.0 ( male ) , &lt; 11.0 ( female ) Patient clinically significant anxiety disorder Patient therapeutic anticoagulation medication INR &gt; 1.3 Patient severe bleed disorder Patient know addiction drug alcohol , include , limited : chronic daily use narcotic medication 90 day prior surgery Patient pregnant Patient prisoner Patient involve personal litigation ( e.g . Worker 's Compensation ) relate knee surgery Patient actively participate another medical device , drug , biologic clinical trial ( active define treatment within last 30 day )</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2013</verification_date>
	<keyword>PRP , TKA , pain scale , hemoglobin , hematocrit , narcotic</keyword>
</DOC>